GM
Golden Minerals Co (AUMN)·Q2 2023 Earnings Summary
Executive Summary
- Revenue was $4.973M, down 16% year over year and up 18% sequentially; net loss narrowed to $1.488M (EPS $(0.21)) vs $(2.813)M (EPS $(0.42)) in Q2 2022 and $(3.266)M (EPS $(0.02)) in Q1 2023 .
- Operations at Rodeo wound down (mining ended in June); management shifted focus to restarting Velardeña on improved concentrate terms, contingent on financing; Rodeo delivered a modest operating margin while Velardeña concentrate sales provided the bulk of net operating margin .
- Liquidity is the central risk: cash was $3.393M at quarter-end, current liabilities $5.389M, and management warned that without near‑term capital the company “will be forced to liquidate” potentially before Q4 2023; financing needs total ~$3–$6M to bridge restart and corporate costs .
- Corporate actions: a 1‑for‑25 reverse stock split took effect June 9; the company raised ~$2.1M gross via registered direct + private placement and ~$1.8M net via ATM during H1 2023; NYSE American accepted a compliance plan for the $6M equity requirement .
- No Q2 2023 earnings call transcript was available; narrative is drawn from the 8‑K press release, production update, and 10‑Q .
What Went Well and What Went Wrong
What Went Well
- Velardeña concentrate sales began and contributed $1.2M of revenue in Q2, with an estimated $1.1M net operating margin under improved offtake terms; this supports the planned restart without a BIOX plant .
- Rodeo delivered a positive operating margin of ~$0.2M in Q2 even as mining concluded, aided by slag sales and processing of stockpiles .
- Sequential improvement in loss from operations: Q2 operating loss of $(1.619)M vs $(3.235)M in Q1, reflecting lower exploration and COGS .
- Management quote: “We intend to restart mining operations at Velardeña Properties, pending sufficient financing… Velardeña… last operated in late 2015” .
What Went Wrong
- Liquidity and going-concern risk escalated: cash fell to $3.393M and management warned of potential liquidation absent near-term capital; forecasted non-COGS cash needs are ~$7.6M for the next 12 months .
- Rodeo grades declined as the mine ended, reducing doré revenue ($3.5M doré in Q2 vs $5.9M in Q2 2022); payable gold ounces sold fell sharply, pressuring revenue .
- Compliance and legal overhangs: NYSE American equity deficiency (plan under review) and the Unifin lawsuit in Mexico (accounts frozen for ~$153K, potential exposure claimed up to $12.5M) .
Financial Results
Revenue, EPS, and Profitability vs prior periods and estimates
Notes:
- No Wall Street consensus EPS/revenue estimates available via S&P Global for Q2 2023; comparisons to estimates are unavailable.
Segment view (company reporting basis)
KPIs (Operations)
Balance sheet highlights:
- Cash & equivalents: $3.393M (June 30) ; Current liabilities: $5.389M ; Short‑term investments: $0.011M .
- Zero debt reported .
Guidance Changes
Earnings Call Themes & Trends
No Q2 2023 earnings call transcript available; themes synthesized from filings and press releases.
Management Commentary
- “The Company announced in June that it intends to restart mining operations at its Velardeña Properties, pending obtaining sufficient financing… Velardeña is a silver‑gold underground mine property located in Durango State, Mexico that Golden last operated in late 2015.”
- “Without additional near‑term capital… the Company will be forced to liquidate its business, potentially before the fourth quarter of 2023.”
- “Projected operating margins during the third quarter of 2023 at Rodeo are expected to range between zero and negative $0.5 million.”
- “We are engaged in several discussions for the sale of assets… equity and/or debt financing… streaming or royalty arrangements… [and] monetize some or all of our $2.9 million VAT receivable in Mexico.”
Q&A Highlights
No earnings call transcript available for Q2 2023. Key investor questions addressed via filings:
- Liquidity runway and plan: Management targets $3–$6M of near‑term capital via asset sales, ATM/equity, or royalty/stream to bridge to Velardeña restart and corporate costs .
- Velardeña economics without BIOX: Improved concentrate terms underpin restart plan; early sales generated $1.2M revenue in Q2 .
- Rodeo wind‑down: Q3 margins guided to ~breakeven to modest loss during stockpile processing .
- Exchange listing: Reverse split completed; NYSE American compliance plan accepted for review .
- Legal proceedings: Settlement talks with Unifin; ~$153K frozen, potential adverse outcome could affect Velardeña restart .
Estimates Context
- S&P Global consensus estimates for Q2 2023 EPS and revenue were unavailable; therefore, we cannot assess beats/misses vs Wall Street for the quarter. Management did not provide formal revenue/EPS guidance ranges; qualitative guidance focused on operating margins and financing needs .
Key Takeaways for Investors
- Liquidity risk is the dominant driver near‑term; absent ~$3–$6M of capital, the company may face liquidation in Q3—position sizing should reflect binary financing outcomes .
- Velardeña restart is the strategic pivot: improved offtake terms and initial concentrate sales de‑risk processing; funding the restart (~$2–$3M) is the key catalyst for the equity .
- Rodeo’s wind‑down reduces doré revenue; expect near‑term margin pressure until Velardeña contributes—monitor Q3 Rodeo margin range (zero to $(0.5)M) .
- Corporate actions (reverse split, ATM, registered direct/private placement) stabilized equity metrics and added cash; continued capital markets access remains critical .
- Legal and listing overhangs persist (Unifin lawsuit; NYSE equity plan under review); resolution timelines will influence restart and capital access .
- Mexico mining law changes raise execution complexity but are not expected to impede current Velardeña plans—still a factor to watch for permitting timelines and costs .
- Trading lens: stock likely to react to financing announcements, Velardeña restart execution, and any update on going‑concern status; downside skew if capital is delayed, upside if restart proceeds on schedule .
Additional Q2 2023 Materials Reviewed
- Q2 2023 8‑K earnings press release (Exhibit 99.1)
- Q2 2023 production update (8‑K, July 20)
- Q2 2023 10‑Q (filed Aug 9)
Prior quarter references for trend:
- Q1 2023 10‑Q (filed May 10)
- Q4/FY 2022 production release (Jan 11)